The Synergistic Metastases Annihilation With Radiotherapy and Docetaxel (Taxotere) [SMART] Trial for Non-Small Cell Lung Cancer (NSCLC)

Summary

Primary goal of the study is to assess the overall survival of the addition of hypofractionated image guided radiotherapy concurrently with Docetaxel and cisplatin. Survival will be assessed at 1 year from the date of study enrollment to date of death.

Timeline

Start

2009-04

Primary completion

2011-03

Completion

2011-06

Outcome

Outcome not reported

Stopped (Enrollment): “Slow accrual and loss of sponsor”

Drugs

Indications